Multiple myeloma is a rare but frequently deadly cancer.
It strikes bone marrow and is most frequently seen in older people -- it's very rare to be diagnosed when younger than 30, and only 10 percent of cases are those under the age of 50.
"The treatment for disease has resulted in progressive increase in immediate survival. It's not a single disease, hard to describe it for a patient but the survival in years and decades is possible," said Dr. Chaim Sustik.
The median age of survival after being diagnosed is now five years, up from just two years 30 years ago.
The improvement is the result of continual, ongoing clinical trials on new drugs and other therapies.
Watch the full interview.
